Why Bigger Isn't Always Better: The Hidden Crisis of the Biotech Industry

From Dior to De Beers – why cufflinks are suddenly the new status symbol in the high-jewellery scene

The new miracle drug CagriSema disappoints the markets – how a target of 25% weight loss is shaking up the billion-dollar obesity market

Big Tech is investing "full throttle" – and Broadcom is riding the wave until 2030.

With "Zepbound," Eli Lilly revolutionizes the treatment of sleep apnea and solidifies its lead in the billion-dollar anti-obesity market.

A deal with signal effect: VW secures jobs and reduces capacities in Germany while the battle for market share rages worldwide.

The EU is struggling with its competitiveness, while in the USA deregulation and Elon Musk set the tone. Is Europe's future trapped in the green haze?

A revolution in aviation: Boeing secures the biggest deal of the year and overshadows the competition

FedEx surprises with bold plan: The logistics giant spins off its freight division and boosts stock markets

The future of Altera is at stake – Intel demands hot bids from industry giants and investors.

With its mysterious blind box toys and clever design, Pop Mart from China has triggered a global collector hype – and the stock is skyrocketing.

How Vast Space LLC is working with SpaceX and NASA on the future of commercial spaceflight – a race against giants like Blue Origin and Axiom Space

Nike battles declining coolness factor and tougher competition – CEO Elliott Hill faces his first test